HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.

Abstract
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report four pediatric HCT recipients with d-ADV treated successfully with BCV.
AuthorsShuk Ying Chan, Susan E Prockop, Farid Boulad, Genovefa A Papanicolaou, Yeon Joo Lee
JournalInfection & chemotherapy (Infect Chemother) Vol. 53 Issue 3 Pg. 572-577 (Sep 2021) ISSN: 2093-2340 [Print] Korea (South)
PMID32869551 (Publication Type: Case Reports)
CopyrightCopyright © 2021 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: